Search results
Nifty 50 July series: From Vedanta to Biocon—4 stocks where investors can park their money; Do you...
Livemint· 4 days agoDomestic equity benchmarks Sensex and Nifty 50 ended June with their best gain in 2024, boosted by...
Buy Biocon; target of Rs 400: Sharekhan
CNBC Awaaz· 3 days agoSharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 400 in its research report dated June 28, 2024.
Biocon - Meeting Conducted With Institutional Investors/ Research Analysts
CNBC Awaaz· 3 days agoBiocon - Meeting Conducted With Institutional Investors/ Research Analysts
Biocon Biologics Receives EMA Approval to Manufacture Bevacizumab in India
SiliconIndia· 6 days agoTeam siliconindiaBiocon Biologics, a subsidiary of Biocon, received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab in India. This ...
MC Inside Edge: Operators gear up for second innings in GNFC, Biocon finds new believers, broker...
CNBC Awaaz· 6 days agoA group of Gujarat-based operators is having another go at the GNFC stock. The stock jumped 2.8x...
Budget 2024 | Research-linked incentive scheme, need of the hour: Kiran Mazumdar-Shaw
Financial Express· 3 days agoBudget 2024: Kiran Mazumdar-Shaw, Executive Chairperson, Biocon and Biocon Biologics has been each...
Dividend Stocks: M&M, Piramal Ent, Tata Power, among others to trade ex-dividend next week; Check...
Livemint· 5 days agoDividend Stocks: Several companies including Mahindra & Mahindra, Piramal Enterprises, Tata Power,...
Praj Industries, NOCIL, Affle India, Chola Invest, Safari Ind and more: B&K lists top 10 stock picks...
Livemint· 2 days agoB&K Securities releases top stock picks for July, including Affle India, Cholamandalam Investment,...
Nifty rides with bulls, can hit 24,600: Analysts
The Economic Times· 4 days agoNifty could extend its gains as momentum remains strong with technical charts suggesting a positive bias. Analysts recommend stocks such as Reliance,...
Stock market update: Nifty Pharma index advances 0.63% in an upbeat market
The Economic Times· 13 hours agoThe Nifty Pharma index was trading 0.63 per cent up at 20041.0.